Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 300

1.

Targeting Mutated Plus Germline Epitopes Confers Pre-clinical Efficacy of an Instantly Formulated Cancer Nano-Vaccine.

Mohsen MO, Vogel M, Riether C, Muller J, Salatino S, Ternette N, Gomes AC, Cabral-Miranda G, El-Turabi A, Ruedl C, Kundig TM, Dermime S, Knuth A, Speiser DE, Bachmann MF.

Front Immunol. 2019 May 15;10:1015. doi: 10.3389/fimmu.2019.01015. eCollection 2019.

2.

Correction to: Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO, Heath MD, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, Stein JV, Riether C, Roesti E, Zha L, Engeroff P, El-Turabi A, Kundig TM, Vogel M, Skinner MA, Speiser DE, Knuth A, Kramer MF, Bachmann MF.

J Immunother Cancer. 2019 May 23;7(1):137. doi: 10.1186/s40425-019-0616-y.

3.

Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.

Mohsen MO, Heath MD, Cabral-Miranda G, Lipp C, Zeltins A, Sande M, Stein JV, Riether C, Roesti E, Zha L, Engeroff P, El-Turabi A, Kundig TM, Vogel M, Skinner MA, Speiser DE, Knuth A, Kramer MF, Bachmann MF.

J Immunother Cancer. 2019 Apr 26;7(1):114. doi: 10.1186/s40425-019-0587-z. Erratum in: J Immunother Cancer. 2019 May 23;7(1):137.

4.

[Access to public physical activity programs in Brazil: National Health Survey, 2013].

Ferreira RW, Caputo EL, Häfele CA, Jerônimo JS, Florindo AA, Knuth AG, Silva MCD.

Cad Saude Publica. 2019 Feb 18;35(2):e00008618. doi: 10.1590/0102-311X00008618. Portuguese.

5.

A phase I/IIa study of the mRNA-based cancer immunotherapy CV9201 in patients with stage IIIB/IV non-small cell lung cancer.

Sebastian M, Schröder A, Scheel B, Hong HS, Muth A, von Boehmer L, Zippelius A, Mayer F, Reck M, Atanackovic D, Thomas M, Schneller F, Stöhlmacher J, Bernhard H, Gröschel A, Lander T, Probst J, Strack T, Wiegand V, Gnad-Vogt U, Kallen KJ, Hoerr I, von der Muelbe F, Fotin-Mleczek M, Knuth A, Koch SD.

Cancer Immunol Immunother. 2019 May;68(5):799-812. doi: 10.1007/s00262-019-02315-x. Epub 2019 Feb 15.

PMID:
30770959
6.

β6 -integrin serves as a novel serum tumor marker for colorectal carcinoma.

Bengs S, Becker E, Busenhart P, Spalinger MR, Raselli T, Kasper S, Lang S, Atrott K, Mamie C, Vavricka SR, von Boehmer L, Knuth A, Tuomisto A, Mäkinen MJ, Hruz P, Turina M, Rickenbacher A, Petrowsky H, Weber A, Frei P, Halama M, Jenkins G, Sheppard D, Croner RS, Christoph J, Britzen-Laurent N, Naschberger E, Schellerer V, Stürzl M, Fried M, Rogler G, Scharl M.

Int J Cancer. 2019 Aug 1;145(3):678-685. doi: 10.1002/ijc.32137. Epub 2019 Jan 29.

PMID:
30653264
7.

Interferons Transcriptionally Up-Regulate MLKL Expression in Cancer Cells.

Knuth AK, Rösler S, Schenk B, Kowald L, van Wijk SJL, Fulda S.

Neoplasia. 2019 Jan;21(1):74-81. doi: 10.1016/j.neo.2018.11.002. Epub 2018 Dec 3.

8.

[Body practices/physical activity in the 30 years of the Unified Health System].

Loch MR, Knuth AG, Silva ICM, Guerra PH.

Cien Saude Colet. 2018 Oct;23(10):3469. doi: 10.1590/1413-812320182310.19102018. Portuguese. No abstract available.

9.

Efficacy of selective digestive decontamination in patients with multiple myeloma undergoing high-dose chemotherapy and autologous stem cell transplantation.

Mürner CM, Stenner-Liewen F, Seifert B, Mueller NJ, Schmidt A, Renner C, Schanz U, Knuth A, Manz MG, Scharl M, Gerber B, Samaras P.

Leuk Lymphoma. 2019 Mar;60(3):685-695. doi: 10.1080/10428194.2018.1496332. Epub 2018 Aug 21.

PMID:
30126310
10.

Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.

Siebenhüner AR, Seifert H, Bachmann H, Seifert B, Winder T, Feilchenfeldt J, Breitenstein S, Clavien PA, Stupp R, Knuth A, Pestalozzi B, Samaras P.

BMC Cancer. 2018 Jan 11;18(1):72. doi: 10.1186/s12885-017-3967-0.

11.

Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.

Kennedy A, Brown DB, Feilchenfeldt J, Marshall J, Wasan H, Fakih M, Gibbs P, Knuth A, Sangro B, Soulen MC, Pittari G, Sharma RA.

J Gastrointest Oncol. 2017 Dec;8(6):1079-1099. doi: 10.21037/jgo.2017.09.10. Review.

12.

Phase I study of a chloroquine-gemcitabine combination in patients with metastatic or unresectable pancreatic cancer.

Samaras P, Tusup M, Nguyen-Kim TDL, Seifert B, Bachmann H, von Moos R, Knuth A, Pascolo S.

Cancer Chemother Pharmacol. 2017 Nov;80(5):1005-1012. doi: 10.1007/s00280-017-3446-y. Epub 2017 Oct 4.

PMID:
28980060
13.

Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.

Cekay MJ, Roesler S, Frank T, Knuth AK, Eckhardt I, Fulda S.

Cancer Lett. 2017 Dec 1;410:228-237. doi: 10.1016/j.canlet.2017.09.002. Epub 2017 Sep 18.

PMID:
28923396
14.

Hematopoietic stem cell transplantation in qatar: One-year anniversary.

Bakr M, Al-Hijji I, Menasria N, Merenkov Z, Al-Azzawi S, Taha R, Gulied A, Gillespie CA, Dermime S, Liakopoulou E, Knuth A.

Hematol Oncol Stem Cell Ther. 2017 Dec;10(4):299-302. doi: 10.1016/j.hemonc.2017.06.002. Epub 2017 Jun 29.

15.

Objectively-measured physical activity in children is influenced by social indicators rather than biological lifecourse factors: Evidence from a Brazilian cohort.

Knuth AG, Silva ICM, van Hees VT, Cordeira K, Matijasevich A, Barros AJD, Santos I, Ekelund U, Hallal PC.

Prev Med. 2017 Apr;97:40-44. doi: 10.1016/j.ypmed.2016.12.051. Epub 2016 Dec 31.

16.

Precision Medicine and Non-Colorectal Cancer Liver Metastases: Fiction or Reality?

Liakopoulou E, Knuth A.

Viszeralmedizin. 2015 Dec;31(6):434-9. doi: 10.1159/000442485. Epub 2015 Dec 4. Review.

17.

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).

Feilchenfeldt J, Varga Z, Siano M, Grabsch HI, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Khanfir K, Diebold J, Jochum W, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Hofer S.

Br J Cancer. 2015 Dec 22;113(12):1747. doi: 10.1038/bjc.2015.458. No abstract available.

18.

Short Peptide Vaccine Induces CD4+ T Helper Cells in Patients with Different Solid Cancers.

Gross S, Lennerz V, Gallerani E, Mach N, Böhm S, Hess D, von Boehmer L, Knuth A, Ochsenbein A, Gnad-Vogt U, Forssmann U, Woelfel T, Kaempgen E.

Cancer Immunol Res. 2016 Jan;4(1):18-25. doi: 10.1158/2326-6066.CIR-15-0105. Epub 2015 Nov 12.

19.

Brain metastases in gastro-oesophageal adenocarcinoma: insights into the role of the human epidermal growth factor receptor 2 (HER2).

Feilchenfeldt J, Varga Z, Siano M, Grabsch HI, Held U, Schuknecht B, Trip A, Hamaguchi T, Gut P, Balague O, Khanfir K, Diebold J, Jochum W, Shoji H, Kushima R, Wagner D, Shimada Y, Cats A, Knuth A, Moch H, Aebi S, Hofer S.

Br J Cancer. 2015 Sep 1;113(5):716-21. doi: 10.1038/bjc.2015.279. Epub 2015 Aug 27. Erratum in: Br J Cancer. 2015 Dec 22;113(12):1747.

20.

Rational Combination of Immunotherapies with Clinical Efficacy in Mice with Advanced Cancer.

Bransi A, Salgado OC, Beffinger M, Milo K, Silina K, Yagita H, Becher B, Knuth A, van den Broek M.

Cancer Immunol Res. 2015 Nov;3(11):1279-88. doi: 10.1158/2326-6066.CIR-15-0103-T. Epub 2015 Jul 3.

21.

Consensus nomenclature for CD8+ T cell phenotypes in cancer.

Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, Comin-Anduix B, Coukos G, Dhodapkar MV, Dranoff G, Frazer IH, Fridman WH, Gabrilovich DI, Gilboa E, Gnjatic S, Jäger D, Kalinski P, Kaufman HL, Kiessling R, Kirkwood J, Knuth A, Liblau R, Lotze MT, Lugli E, Marincola F, Melero I, Melief CJ, Mempel TR, Mittendorf EA, Odun K, Overwijk WW, Palucka AK, Parmiani G, Ribas A, Romero P, Schreiber RD, Schuler G, Srivastava PK, Tartour E, Valmori D, van der Burg SH, van der Bruggen P, van den Eynde BJ, Wang E, Zou W, Whiteside TL, Speiser DE, Pardoll DM, Restifo NP, Anderson AC.

Oncoimmunology. 2015 Feb 25;4(4):e998538. eCollection 2015 Apr.

22.

Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response.

Surace L, Lysenko V, Fontana AO, Cecconi V, Janssen H, Bicvic A, Okoniewski M, Pruschy M, Dummer R, Neefjes J, Knuth A, Gupta A, van den Broek M.

Immunity. 2015 Apr 21;42(4):767-77. doi: 10.1016/j.immuni.2015.03.009. Epub 2015 Apr 14.

23.

Classification of current anticancer immunotherapies.

Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, Bracci L, Caignard A, Castelli C, Cavallo F, Celis E, Cerundolo V, Clayton A, Colombo MP, Coussens L, Dhodapkar MV, Eggermont AM, Fearon DT, Fridman WH, Fučíková J, Gabrilovich DI, Galon J, Garg A, Ghiringhelli F, Giaccone G, Gilboa E, Gnjatic S, Hoos A, Hosmalin A, Jäger D, Kalinski P, Kärre K, Kepp O, Kiessling R, Kirkwood JM, Klein E, Knuth A, Lewis CE, Liblau R, Lotze MT, Lugli E, Mach JP, Mattei F, Mavilio D, Melero I, Melief CJ, Mittendorf EA, Moretta L, Odunsi A, Okada H, Palucka AK, Peter ME, Pienta KJ, Porgador A, Prendergast GC, Rabinovich GA, Restifo NP, Rizvi N, Sautès-Fridman C, Schreiber H, Seliger B, Shiku H, Silva-Santos B, Smyth MJ, Speiser DE, Spisek R, Srivastava PK, Talmadge JE, Tartour E, Van Der Burg SH, Van Den Eynde BJ, Vile R, Wagner H, Weber JS, Whiteside TL, Wolchok JD, Zitvogel L, Zou W, Kroemer G.

Oncotarget. 2014 Dec 30;5(24):12472-508. Review.

24.

Physical activity levels in three Brazilian birth cohorts as assessed with raw triaxial wrist accelerometry.

da Silva IC, van Hees VT, Ramires VV, Knuth AG, Bielemann RM, Ekelund U, Brage S, Hallal PC.

Int J Epidemiol. 2014 Dec;43(6):1959-68. doi: 10.1093/ije/dyu203. Epub 2014 Oct 30.

25.

Uncommon case of brain metastasis in a patient with a history of heavy smoking.

Scharl M, Bode B, Rushing E, Knuth A, Rordorf T.

Curr Oncol. 2014 Oct;21(5):e728-31. doi: 10.3747/co.21.1880.

26.

Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cells.

Knuth A, Liu L, Nielsen H, Merril D, Torry DS, Arroyo JA.

Am J Reprod Immunol. 2015 Apr;73(4):330-40. doi: 10.1111/aji.12327. Epub 2014 Oct 1.

PMID:
25271148
27.

Neutrophil expression of ICAM1, CXCR1, and VEGFR1 in patients with breast cancer before and after adjuvant chemotherapy.

Lohri C, Schaltegger CS, VAN DEN Broek M, Wenger RH, Ruegg C, Fink D, Fehr MK, Knuth A, Zweifel M.

Anticancer Res. 2014 Sep;34(9):4693-9.

28.

Challenges in adapting international best practices in cancer prevention, care, and research for Qatar.

Howitt PJ, Kerr K, Al Kuwari H, Mohamed Husain Ali F, Knuth A, Darzi A.

Health Aff (Millwood). 2014 Sep;33(9):1635-40. doi: 10.1377/hlthaff.2014.0381.

29.

Innovation can improve and expand aspects of end-of-life care in low- and middle-income countries.

Steedman MR, Hughes-Hallett T, Knaul FM, Knuth A, Shamieh O, Darzi A.

Health Aff (Millwood). 2014 Sep;33(9):1612-9. doi: 10.1377/hlthaff.2014.0379.

30.

Ten-year trends in total physical activity practice in Brazilian adults: 2002-2012.

Hallal PC, Cordeira K, Knuth AG, Mielke GI, Victora CG.

J Phys Act Health. 2014 Nov;11(8):1525-30. doi: 10.1123/jpah.2013-0031. Epub 2014 Jun 5.

PMID:
24905186
31.

Chromosomal aberrations of cancer-testis antigens in myeloma patients.

Curioni-Fontecedro A, Martin V, Vogetseder A, Knuth A, Moch H, Soldini D, Tinguely M.

Hematol Oncol. 2015 Sep;33(3):159-63. doi: 10.1002/hon.2143. Epub 2014 May 13.

PMID:
24820892
32.

Long-term complete remission following radiosurgery and immunotherapy in a melanoma patient with brain metastasis: immunologic correlates.

Karbach J, Gnjatic S, Biskamp M, Atmaca A, Weidmann E, Brandt K, Wahle C, Bernhard H, Knuth A, Jäger E.

Cancer Immunol Res. 2014 May;2(5):404-9. doi: 10.1158/2326-6066.CIR-13-0200. Epub 2014 Feb 5.

33.

Spontaneous peripheral T-cell responses toward the tumor-associated antigen cyclin D1 in patients with clear cell renal cell carcinoma.

Dannenmann SR, Hermanns T, Bransi A, Matter C, von Boehmer L, Stevanovic S, Schraml P, Moch H, Knuth A, van den Broek M.

Cancer Immunol Res. 2013 Nov;1(5):288-95. doi: 10.1158/2326-6066.CIR-13-0113. Epub 2013 Sep 25.

34.

Imagine a world without cancer.

Brücher BL, Lyman G, van Hillegersberg R, Pollock RE, Lordick F, Yang HK, Ushijima T, Yeoh KG, Skricka T, Polkowski W, Wallner G, Verwaal V, Garofalo A, D'Ugo D, Roviello F, Steinau HU, Wallace TJ, Daumer M, Maihle N, Reid TJ 3rd, Ducreux M, Kitagawa Y, Knuth A, Zilberstein B, Steele SR, Jamall IS.

BMC Cancer. 2014 Mar 14;14:186. doi: 10.1186/1471-2407-14-186.

35.

Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors.

Lennerz V, Gross S, Gallerani E, Sessa C, Mach N, Boehm S, Hess D, von Boehmer L, Knuth A, Ochsenbein AF, Gnad-Vogt U, Zieschang J, Forssmann U, Woelfel T, Kaempgen E.

Cancer Immunol Immunother. 2014 Apr;63(4):381-94. doi: 10.1007/s00262-013-1516-5. Epub 2014 Feb 2.

PMID:
24487961
36.

Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.

Laban S, Atanackovic D, Luetkens T, Knecht R, Busch CJ, Freytag M, Spagnoli G, Ritter G, Hoffmann TK, Knuth A, Sauter G, Wilczak W, Blessmann M, Borgmann K, Muenscher A, Clauditz TS.

Int J Cancer. 2014 Sep 1;135(5):1142-52. doi: 10.1002/ijc.28752. Epub 2014 Feb 11.

37.

Tumor imaging in patients with advanced tumors using a new (99m) Tc-radiolabeled vitamin B12 derivative.

Sah BR, Schibli R, Waibel R, von Boehmer L, Bläuenstein P, Nexo E, Johayem A, Fischer E, Müller E, Soyka JD, Knuth AK, Haerle SK, Schubiger PA, Schaefer NG, Burger IA.

J Nucl Med. 2014 Jan;55(1):43-9. doi: 10.2967/jnumed.113.122499. Epub 2013 Dec 12.

38.

Status of hepatocellular carcinoma in Gulf region.

Rasul KI, Al-Azawi SH, Chandra P, Abou-Alfa GK, Knuth A.

Chin Clin Oncol. 2013 Dec;2(4):42. doi: 10.3978/j.issn.2304-3865.2013.11.02.

39.

Cancer testis antigen expression in testicular germ cell tumorigenesis.

Bode PK, Thielken A, Brandt S, Barghorn A, Lohe B, Knuth A, Moch H.

Mod Pathol. 2014 Jun;27(6):899-905. doi: 10.1038/modpathol.2013.183. Epub 2013 Nov 15.

40.

Trends in leisure-time physical activity in a southern Brazilian city: 2003-2010.

da Silva IC, Knuth AG, Mielke GI, Azevedo MR, Gonçalves H, Hallal PC.

J Phys Act Health. 2014 Sep;11(7):1313-7. doi: 10.1123/jpah.2012-0460. Epub 2013 Oct 31.

PMID:
24176929
41.

Successful Salvage Chemotherapy with FOLFIRINOX for Recurrent Mixed Acinar Cell Carcinoma and Ductal Adenocarcinoma of the Pancreas in an Adolescent Patient.

Pfrommer S, Weber A, Dutkowski P, Schäfer NG, Müllhaupt B, Bourquin JP, Breitenstein S, Pestalozzi BC, Stenner F, Renner C, D'Addario G, Graf HJ, Knuth A, Clavien PA, Samaras P.

Case Rep Oncol. 2013 Sep 28;6(3):497-503. doi: 10.1159/000355320. eCollection 2013.

42.

Time trends of physical activity among Brazilian adolescents over a 7-year period.

Coll Cde V, Knuth AG, Bastos JP, Hallal PC, Bertoldi AD.

J Adolesc Health. 2014 Feb;54(2):209-13. doi: 10.1016/j.jadohealth.2013.08.010. Epub 2013 Oct 22.

PMID:
24161586
43.

Daily Pomegranate Intake Has No Impact on PSA Levels in Patients with Advanced Prostate Cancer - Results of a Phase IIb Randomized Controlled Trial.

Stenner-Liewen F, Liewen H, Cathomas R, Renner C, Petrausch U, Sulser T, Spanaus K, Seifert HH, Strebel RT, Knuth A, Samaras P, Müntener M.

J Cancer. 2013 Aug 29;4(7):597-605. doi: 10.7150/jca.7123. eCollection 2013.

44.

NY-ESO-1-specific immunological pressure and escape in a patient with metastatic melanoma.

von Boehmer L, Mattle M, Bode P, Landshammer A, Schäfer C, Nuber N, Ritter G, Old L, Moch H, Schäfer N, Jäger E, Knuth A, van den Broek M.

Cancer Immun. 2013 Jul 15;13:12. Print 2013.

45.

Radiotherapy of human sarcoma promotes an intratumoral immune effector signature.

Sharma A, Bode B, Studer G, Moch H, Okoniewski M, Knuth A, von Boehmer L, van den Broek M.

Clin Cancer Res. 2013 Sep 1;19(17):4843-53. doi: 10.1158/1078-0432.CCR-13-0352. Epub 2013 Jul 16.

46.

RP1 is a phosphorylation target of CK2 and is involved in cell adhesion.

Stenner F, Liewen H, Göttig S, Henschler R, Markuly N, Kleber S, Faust M, Mischo A, Bauer S, Zweifel M, Knuth A, Renner C, Wadle A.

PLoS One. 2013 Jul 3;8(7):e67595. doi: 10.1371/journal.pone.0067595. Print 2013.

47.

Computed tomographic perfusion imaging for the prediction of response and survival to transarterial radioembolization of liver metastases.

Morsbach F, Pfammatter T, Reiner CS, Fischer MA, Sah BR, Winklhofer S, Klotz E, Frauenfelder T, Knuth A, Seifert B, Schaefer N, Alkadhi H.

Invest Radiol. 2013 Nov;48(11):787-94. doi: 10.1097/RLI.0b013e31829810f7.

PMID:
23748229
48.

Prognostic factors for survival in lymphoma patients after autologous stem cell transplantation.

Samaras P, Zardavas D, Petrausch U, Buset EM, Haile SR, Honegger H, Siciliano RD, Schanz U, Mischo A, Schäfer NG, Taverna C, Knuth A, Stahel R, Renner C, Stenner-Liewen F.

Swiss Med Wkly. 2013 May 7;143:w13791. doi: 10.4414/smw.2013.13791. eCollection 2013. No abstract available.

49.

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.

Dannenmann SR, Thielicke J, Stöckli M, Matter C, von Boehmer L, Cecconi V, Hermanns T, Hefermehl L, Schraml P, Moch H, Knuth A, van den Broek M.

Oncoimmunology. 2013 Mar 1;2(3):e23562.

50.

[Methodological description of accelerometry for measuring physical activity in the 1993 and 2004 Pelotas (Brazil) birth cohorts].

Knuth AG, Assunção MC, Gonçalves H, Menezes AM, Santos IS, Barros AJ, Matijasevich A, Ramires VV, Silva IC, Hallal PC.

Cad Saude Publica. 2013 Mar;29(3):557-65. Portuguese.

Supplemental Content

Support Center